Medication info
International Pioglitazone Tablet 30 mg (Pioglitazone Hydrochloride)

International Pioglitazone Tablet 30 mg (Pioglitazone Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Pioglitazone Hydrochloride›33.06mg / 1 tablet
Manufacturer / importer
International Pharmaceutical Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201801324 · Approved 2018.03.27 · Insurance code 643704540

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
This drug is administered orally once daily, without regard to meals. 1. Monotherapy This drug may be started at 15 mg once daily, and, if the effect is insufficient, the dose may be increased to 30 mg once daily. 2. Combination therapy When used in combination with a sulfonylurea, metformin, or insulin, the initial dose is 15 mg once daily. The maximum recommended dose is 30 mg once daily.
Child dose
Use is not recommended in children under 18 years of age because there is no experience with its use in this age group.

Ingredients

Manufacturer
International Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood glucose control in patients with type 2 diabetes
View approved original text

This medication is used alongside dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone, and if no improvement is observed with other oral hypoglycemic agents, it may be used in combination with sulfonylureas, metformin, or insulin. Additionally, it is important for patients to engage in nutritional counseling and weight loss, as well as exercise, as these efforts are crucial not only for initial treatment but also for maintaining the effectiveness of drug therapy. Therefore, this medication is used for improving blood glucose control in patients with type 2 diabetes.

How to take

Adult dose

This drug is administered orally once daily, without regard to meals. 1. Monotherapy This drug may be started at 15 mg once daily, and, if the effect is insufficient, the dose may be increased to 30 mg once daily. 2. Combination therapy When used in combination with a sulfonylurea, metformin, or insulin, the initial dose is 15 mg once daily. The maximum recommended dose is 30 mg once daily.

Child dose

Use is not recommended in children under 18 years of age because there is no experience with its use in this age group.

Precautions

This medication is used for the treatment of type 2 diabetes and helps improve insulin resistance to control blood sugar. During the course of treatment with this medication, it may place a burden on the heart, so it should not be given to patients with congestive heart failure or a history of heart failure. Symptoms of heart failure such as weight changes, shortness of breath, and swelling should be closely monitored after starting treatment or increasing the dose, and if any symptoms appear, immediate consultation with a healthcare professional is necessary. This medication can cause fluid retention, worsening heart failure, so it should be used cautiously in patients with heart disease or those at high risk of fluid retention. Patients with active bladder cancer or a history of bladder cancer should not receive this medication, and if symptoms of hematuria or urinary disorders occur during treatment, they should be reported to a doctor immediately. Patients with impaired liver function, severe kidney disease, or diabetic ketoacidosis should avoid using this medication. Caution is needed when used in conjunction with other oral hypoglycemic agents as the risk of hypoglycemia may increase, particularly when used alongside sulfonylureas or insulin, and symptoms of hypoglycemia should be carefully observed. Common side effects may include swelling, headache, upper respiratory infections, muscle pain, pharyngitis, abdominal bloating, weight gain, urinary tract infection, hypoglycemia, back pain, dizziness, diarrhea, elevated creatine kinase, hypertension, itching, chest pain, fatigue, weakness, indigestion, nausea, chest discomfort, tremors, chills, gastrointestinal disorders, discomfort in the epigastric region, numbness, muscle stiffness, discomfort in the head, increased liver enzymes, hives, eczema, joint pain, knee problems, arm weakness, and protein in urine. This medication may cause weight gain, so regular monitoring of weight changes during treatment is important. It is advisable not to use this medication in pregnant women or women who may become pregnant, and premenopausal women should utilize appropriate contraception while taking this medication as it may induce ovulation. Elderly patients or those with decreased kidney or liver function require more careful monitoring during treatment with this medication. This medication is taken once daily, and care should be taken not to double the dose if a dose is missed on the following day. There may be drug interactions, so if other medications are being taken, it is essential to inform the doctor or pharmacist. During treatment with this medication, regular blood glucose and liver function tests should be conducted to monitor therapeutic effect and side effects. In case of overdose, even without specific symptoms, it is important to visit a medical institution immediately for appropriate treatment. Keep out of reach of children and store the medication in its original container.

Side effects

Congestive heart failure, excessive and rapid weight change, shortness of breath, edema, fluid retention, inadequate blood sugar control, upper respiratory tract infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, cardiovascular-related mortality, hospitalization due to worsening congestive heart failure, emergency room visit due to congestive heart failure, adverse reactions related to edema, elevated serum ALT levels, hepatic failure, diabetic macular edema associated with vision loss, bladder cancer, decreased hemoglobin, elevated serum creatine kinase, dizziness, anorexia, constipation, upper abdominal pain, chest discomfort, fatigue, weakness, indigestion, nausea, shortness of breath, itching, chest unease, tremors, chills, gastrointestinal disorders, abdominal pain, epigastric discomfort, numbness, muscle rigidity, head discomfort, increased liver enzymes, worsening liver disease, urticaria, eczema, arthralgia, knee discomfort, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, cardiac dysfunction, fractures

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that does not allow light and air to penetrate and should be kept away from humid areas. Additionally, to maintain the efficacy of the medication, it is recommended to store it in a cool place at a temperature between 15 and 30 degrees Celsius, preferably around 25 degrees.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.